Morphine Equivalent for 0.2 mg IV Hydromorphone
0.2 mg IV hydromorphone is equivalent to approximately 1.3 mg IV morphine.
Calculation Based on Guidelines
Using the most recent and authoritative conversion data from the 2025 NCCN Adult Cancer Pain Guidelines 1, the standard parenteral conversion shows:
- Hydromorphone IV: 1.5 mg is equianalgesic to Morphine IV: 10 mg
- This establishes a conversion ratio of approximately 1:6.7 (hydromorphone to morphine)
For 0.2 mg IV hydromorphone:
- 0.2 mg ÷ 1.5 mg = 0.133
- 0.133 × 10 mg morphine = 1.33 mg IV morphine
Supporting Evidence
The 2016 CDC Guideline 2 provides a conversion factor of 4 for hydromorphone when calculating morphine milligram equivalents (MME), which applies to oral dosing conversions. However, for IV-to-IV conversions, the NCCN parenteral dosing table is more directly applicable.
The FDA-approved hydromorphone label 3 confirms that the usual IV starting dose is 0.2 mg to 1 mg every 2-3 hours, while the morphine label 4 indicates 0.1 mg to 0.2 mg per kg (approximately 7-14 mg for a 70 kg patient) as typical dosing, supporting the relative potency difference.
Clinical Context
Research evidence consistently demonstrates hydromorphone's higher potency:
- A 2000 pharmacology study 5 found hydromorphone was 10 times as potent as morphine (1 mg hydromorphone = 10 mg morphine)
- A 1975 clinical trial 6 determined 0.9-1.2 mg hydromorphone is equianalgesic with 10 mg morphine
- Emergency department studies 7, 8 used weight-based dosing of 0.015 mg/kg hydromorphone versus 0.1 mg/kg morphine (approximately 1:6.7 ratio)
Important Caveats
Duration of action differs: Hydromorphone has a shorter duration (2-3 hours) compared to morphine (3-4 hours) 1, which may necessitate more frequent dosing intervals despite equianalgesic conversion.
Renal impairment considerations: Both drugs should be used cautiously in patients with fluctuating renal function due to accumulation of renally cleared metabolites 1. Hydromorphone may be preferred in severe renal dysfunction as it has less problematic metabolite accumulation than morphine-6-glucuronide.
Individual variability: While 0.2 mg IV hydromorphone converts to approximately 1.3 mg IV morphine mathematically, clinical response varies. The FDA label 3 emphasizes individualizing doses based on pain severity, prior opioid exposure, and patient-specific factors.